ARHGEF2 and neoplasm: Depletion of Arhgef2 (GEF-H1) and Arhgef17 (Tumour Endothelial Marker 4, TEM4) resulted in a reduced lamellipodia protrusion speed similar to that seen with TRPV4 inhibition.